BIOCELL
Scope & Guideline
Advancing the Frontiers of Cell Biology
Introduction
Aims and Scopes
- Cellular and Molecular Mechanisms:
Research articles focusing on the intricate cellular pathways and molecular mechanisms that govern various biological processes, including cell proliferation, differentiation, apoptosis, and autophagy. - Stem Cell Biology and Regenerative Medicine:
A significant focus on the properties, applications, and therapeutic potentials of stem cells, including their roles in tissue engineering, regeneration, and treatment of various diseases. - Cancer Biology and Therapeutics:
Investigations into the molecular and cellular underpinnings of cancer, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic approaches. - Immunology and Host-Pathogen Interactions:
Studies that explore the immune response to pathogens, the mechanisms of immune evasion by cancer cells, and the development of immunotherapies. - Bioinformatics and Systems Biology:
Utilization of computational methods and bioinformatics tools to analyze large datasets, identify biomarkers, and understand complex biological interactions. - Nanotechnology and Biomaterials:
Research highlighting the application of nanomaterials and biomaterials in biological systems, particularly in drug delivery, diagnostics, and tissue engineering.
Trending and Emerging
- Single-Cell Sequencing and Transcriptomics:
There is a marked increase in studies utilizing single-cell sequencing technologies to explore cellular heterogeneity and gene expression profiles, particularly in cancer and immune responses. - Microbiome and Host Interactions:
Research exploring the gut microbiome's influence on health and disease, including its interactions with host cells and implications for personalized medicine, has emerged as a key area of interest. - Advancements in Nanotechnology:
The application of nanotechnology in drug delivery systems, diagnostics, and therapeutic interventions is increasingly prominent, reflecting the journal's commitment to cutting-edge research. - Cancer Immunotherapy:
A growing body of work focuses on cancer immunotherapy, including the mechanisms of immune evasion and the development of novel immunotherapeutic strategies. - Epigenetic Modifications in Health and Disease:
There is an increasing emphasis on studies investigating the role of epigenetic changes in various diseases, including cancer and metabolic disorders, highlighting their potential as therapeutic targets. - Biomaterials for Tissue Engineering:
Research on innovative biomaterials for tissue engineering applications is gaining momentum, particularly those that enhance cellular interactions and promote regeneration.
Declining or Waning
- Traditional Pharmacological Studies:
There seems to be a decline in publications centered on classical pharmacological approaches, as the journal shifts towards more innovative and integrative methodologies. - In vitro Models with Limited Relevance:
Research utilizing simplistic in vitro models that do not adequately mimic the complexity of in vivo systems appears to be decreasing, as the field moves towards more sophisticated models, including organ-on-a-chip technologies. - Basic Plant Biology Studies:
While still relevant, there is a noticeable reduction in the number of studies solely focused on fundamental plant biology, as the journal pivots towards translational research and applications in human health. - Non-targeted Metabolomics:
The focus on non-targeted metabolomics studies has diminished, likely due to the growing emphasis on targeted approaches that yield more actionable insights in therapeutic contexts. - Animal Studies with Limited Clinical Relevance:
Research involving animal models that do not translate well to human conditions is less frequently published, reflecting a trend towards studies that emphasize translational potential.
Similar Journals
BMC Molecular and Cell Biology
Advancing the frontiers of molecular and cell biology.BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.
Protein & Cell
Connecting Researchers Through Open Access InsightsProtein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.
CELL BIOLOGY INTERNATIONAL
Elevating the Discourse in Cellular ResearchCELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.
BIOSCIENCE REPORTS
Connecting Researchers with Groundbreaking FindingsBIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.
Life Science Alliance
Innovating Open Access for Global Impact.Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.
Cells
Illuminating the World of Cells Through Groundbreaking ResearchCells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
Genes & Diseases
Pioneering research for a healthier tomorrow.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.
Cell Journal
Advancing the Frontiers of Cell ScienceCell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.
GENES TO CELLS
Fostering Innovation in Genetic and Cellular ResearchGENES TO CELLS is a distinguished peer-reviewed journal published by Wiley, offering valuable insights into the intricate world of cell biology and genetics. With an ISSN of 1356-9597 and an E-ISSN of 1365-2443, this journal has been contributing to the academic community since its inception in 1996 and will continue its publishing journey until 2024. Recognized with a category quartile ranking of Q3 in both Cell Biology and Genetics, and Q2 in Medicine (Miscellaneous) as of 2023, it serves as an important platform for disseminating innovative research and reviews in molecular biology and related fields. Although it does not currently offer open access, the journal caters to a diverse readership by providing comprehensive studies that are essential for professionals, researchers, and students aiming to deepen their understanding of genetic mechanisms and cellular functions. Situated in the United Kingdom, GENES TO CELLS continues to play a pivotal role in shaping the future of biological research.
Cell Death & Disease
Illuminating pathways from cell death to disease impact.Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.